Trastuzumab: Anhydramnios and fetal growth retardation following in utero exposure: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1164, 2007-01, pp. : 23-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab: Fetal anhydramnios following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 43-43

Adis International

Access to resources Recommend Favorite

Trastuzumab: Anhydramnios, and fatal pulmonary hypoplasia and atelectasis following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Paclitaxel/trastuzumab: Anhydramnios and renal failure in a fetus following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Carbamazepine/phenobarbital: Severe growth retardation following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Candesartan cilexetil: Anhydramnios, and fatal congenital abnormalities following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite